Showing results (101-110 of 106) with videos related to
Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 106 results.
Lancet (London, England)|February 24, 2023
Mpox in people with advanced HIV infection: a global case seriesOriol Mitjà, Andrea Alemany, Michael Marks, et al.Molecular Cancer Therapeutics|June 21, 2024
The SOS1 Inhibitor MRTX0902 Blocks KRAS Activation and Demonstrates Antitumor Activity in Cancers Dependent on KRAS Nucleotide LoadingNiranjan Sudhakar, Larry Yan, Fadia Qiryaqos, et al.Cancer Discovery|August 8, 2023
MRTX1719 Is an MTA-Cooperative PRMT5 Inhibitor That Exhibits Synthetic Lethality in Preclinical Models and Patients with MTAP-Deleted CancerLars D Engstrom, Ruth Aranda, Laura Waters, et al.The New England Journal of Medicine|June 23, 2021
Acquired Resistance to KRAS<sup>G12C</sup> Inhibition in CancerMark M Awad, Shengwu Liu, Igor I Rybkin, et al.Nature Communications|July 17, 2021
Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIVJeffrey V Lazarus, Kelly Safreed-Harmon, Adeeba Kamarulzaman, et al.The Lancet. HIV|August 7, 2025
Establishing shared definitions of virological failure and discontinuation for long-acting injectable cabotegravir and rilpivirine therapy (the CONSENSUS-LAI Study): an international survey and Delphi processChloe Orkin, Amy Paterson, Alexa Elias, et al.Pageof 11